Venous Thromboembolism (VTE) is a common and life-threatening disease. There are an estimated 900,000 to 1 million VTE events in the United States each year. VTE is the third leading cause of cardiovascular mortality. In fact, hospitalization and nursing home residence together account for almost 60% of incident VTE events occurring in the community. In hospitalized patients, the fatality rate is 12%, rising to 21% in the elderly. The Joint Commission and the Agency for Health Research and Quality (AHRQ) continue to mandate VTE prevention and safety measures1.
AngioVac Cannula and Circuit
The AngioVac venous drainage system includes the Venous Drainage Cannula and Extracorporeal Circuit. The cannula is intended for use as a venous drainage cannula and for the removal of fresh, soft thrombi or emboli during extracorporeal bypass for up to six hours. The extracorporeal circuit is intended for use in procedures requiring extracorporeal circulatory support for periods of up to six hours.